CVS Financial Statements From 2010 to 2024
| 4C9 Stock | EUR 10.60 0.20 1.85% |
Check CVS Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVS Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . CVS financial statements analysis is a perfect complement when working with CVS Group Valuation or Volatility modules.
CVS |
CVS Group plc Company Current Valuation Analysis
CVS Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CVS Group Current Valuation | 1.9 B |
Most of CVS Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Group plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CVS Group plc has a Current Valuation of 1.9 B. This is 89.52% lower than that of the sector and 62.25% lower than that of the Current Valuation industry. The current valuation for all Germany stocks is 88.59% higher than that of the company.
CVS Group plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CVS Group's current stock value. Our valuation model uses many indicators to compare CVS Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CVS Group competition to find correlations between indicators driving CVS Group's intrinsic value. More Info.CVS Group plc is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CVS Group plc is roughly 2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CVS Group's earnings, one of the primary drivers of an investment's value.About CVS Group Financial Statements
CVS Group stakeholders use historical fundamental indicators, such as CVS Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although CVS Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in CVS Group's assets and liabilities are reflected in the revenues and expenses on CVS Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CVS Group plc. Please read more on our technical analysis and fundamental analysis pages.
CVS Group plc engages in veterinary, online pharmacy, and retail businesses. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom. CVS GROUP operates under Personal Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6150 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CVS Stock
CVS Group financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS Group security.